Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

The Winn House, a 1950 Usonian gem, is tucked into a hill and was restored in 2019. Check out photos of one of Frank Lloyd ...

Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.

That’s according to the Deloitte U.S. Center for Health Solutions, which found in a recent survey of 150 C-suite executives ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

Plenty of high-performing growth stocks pay dividends -- such as Apple and Nvidia -- and though their dividend yields can be ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at ...

Pfizer yields 6.53% and trades at 9x earnings, while Altria offers 7.58% at 10.1x earnings. Pfizer's troubling 221% payout ...

NEW DELHI, (Reuters) -The drug company Viatris announced on December 23 that the U.S. Food and Drug Administration (FDA) has ...

A federal court in Massachusetts found in favor of Pfizer, whose oral Covid-19 treatment Paxlovid survived a patent challenge ...